125 related articles for article (PubMed ID: 30053054)
1. Generation and Optimization of a Green Fluorescent Protein-Expressing Transcription and Replication-Competent Virus-Like Particle System for Ebola Virus.
Schmidt ML; Tews BA; Groseth A; Hoenen T
J Infect Dis; 2018 Nov; 218(suppl_5):S360-S364. PubMed ID: 30053054
[TBL] [Abstract][Full Text] [Related]
2. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.
Watt A; Moukambi F; Banadyga L; Groseth A; Callison J; Herwig A; Ebihara H; Feldmann H; Hoenen T
J Virol; 2014 Sep; 88(18):10511-24. PubMed ID: 24965473
[TBL] [Abstract][Full Text] [Related]
3. Modeling the Ebolavirus Life Cycle with Transcription and Replication-Competent Viruslike Particle Assays.
Biedenkopf N; Hoenen T
Methods Mol Biol; 2017; 1628():119-131. PubMed ID: 28573615
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Life Cycle Modeling Systems as Prediction Tools for a Possible Attenuation of Recombinant Ebola Viruses.
Bodmer BS; Hoenen T
Viruses; 2022 May; 14(5):. PubMed ID: 35632785
[TBL] [Abstract][Full Text] [Related]
5. Modeling the lifecycle of Ebola virus under biosafety level 2 conditions with virus-like particles containing tetracistronic minigenomes.
Hoenen T; Watt A; Mora A; Feldmann H
J Vis Exp; 2014 Sep; (91):52381. PubMed ID: 25285674
[TBL] [Abstract][Full Text] [Related]
6. A Rapid Screen for Host-Encoded miRNAs with Inhibitory Effects against Ebola Virus Using a Transcription- and Replication-Competent Virus-Like Particle System.
Wang Z; Li J; Fu Y; Zhao Z; Zhang C; Li N; Li J; Cheng H; Jin X; Lu B; Guo Z; Qian J; Liu L
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772717
[TBL] [Abstract][Full Text] [Related]
7. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
[TBL] [Abstract][Full Text] [Related]
8. Modeling Ebola Virus Genome Replication and Transcription with Minigenome Systems.
Cressey T; Brauburger K; Mühlberger E
Methods Mol Biol; 2017; 1628():79-92. PubMed ID: 28573612
[TBL] [Abstract][Full Text] [Related]
9. Analysis of a Putative Late Domain Using an Ebola Virus Transcription and Replication-Competent Virus-Like Particle System.
Wendt L; Kämper L; Schmidt ML; Mettenleiter TC; Hoenen T
J Infect Dis; 2018 Nov; 218(suppl_5):S355-S359. PubMed ID: 29931371
[TBL] [Abstract][Full Text] [Related]
10. Generation of Recombinant Ebola Viruses Using Reverse Genetics.
Groseth A
Methods Mol Biol; 2017; 1628():177-188. PubMed ID: 28573619
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Search for Competing Endogenous RNAs Responsible for the Effects Induced by Ebola Virus Replication and Transcription Using a trVLP System.
Wang ZY; Guo ZD; Li JM; Zhao ZZ; Fu YY; Zhang CM; Zhang Y; Liu LN; Qian J; Liu LN
Front Cell Infect Microbiol; 2017; 7():479. PubMed ID: 29209594
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle.
Biedenkopf N; Lier C; Becker S
J Virol; 2016 May; 90(10):4914-4925. PubMed ID: 26937028
[TBL] [Abstract][Full Text] [Related]
13. Minigenome Systems for Filoviruses.
Hoenen T
Methods Mol Biol; 2018; 1604():237-245. PubMed ID: 28986839
[TBL] [Abstract][Full Text] [Related]
14. Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.
Welch SR; Guerrero LW; Chakrabarti AK; McMullan LK; Flint M; Bluemling GR; Painter GR; Nichol ST; Spiropoulou CF; Albariño CG
Antiviral Res; 2016 Dec; 136():9-18. PubMed ID: 27771389
[TBL] [Abstract][Full Text] [Related]
15. Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.
Hoenen T; Groseth A; Kolesnikova L; Theriault S; Ebihara H; Hartlieb B; Bamberg S; Feldmann H; Ströher U; Becker S
J Virol; 2006 Jul; 80(14):7260-4. PubMed ID: 16809331
[TBL] [Abstract][Full Text] [Related]
16. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
Nelson EV; Pacheco JR; Hume AJ; Cressey TN; Deflubé LR; Ruedas JB; Connor JH; Ebihara H; Mühlberger E
Antiviral Res; 2017 Oct; 146():21-27. PubMed ID: 28807685
[TBL] [Abstract][Full Text] [Related]
17. An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity.
Tsuda Y; Hoenen T; Banadyga L; Weisend C; Ricklefs SM; Porcella SF; Ebihara H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S129-37. PubMed ID: 25810440
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles.
Yoon YS; Jang Y; Hoenen T; Shin H; Lee Y; Kim M
BMB Rep; 2020 Mar; 53(3):166-171. PubMed ID: 31964466
[TBL] [Abstract][Full Text] [Related]
19. Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription.
Jasenosky LD; Neumann G; Kawaoka Y
Antimicrob Agents Chemother; 2010 Jul; 54(7):3007-10. PubMed ID: 20421407
[TBL] [Abstract][Full Text] [Related]
20. An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.
Li D; Chen T; Hu Y; Zhou Y; Liu Q; Zhou D; Jin X; Huang Z
J Virol; 2016 Oct; 90(19):8720-8. PubMed ID: 27440895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
